Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
Microseminoprotein-beta (MSMB, MSMB) is an abundant secretory protein contributed by the prostate, and is implicated as a prostate cancer (PC) biomarker based on observations of its lower expression in cancerous cells compared with benign prostate epithelium. However, as the current literature on MS...
Main Authors: | Liisa Sjöblom, Outi Saramäki, Matti Annala, Katri Leinonen, Janika Nättinen, Teemu Tolonen, Tiina Wahlfors, Matti Nykter, G Steven Bova, Johanna Schleutker, Teuvo L J Tammela, Hans Lilja, Tapio Visakorpi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0150241&type=printable |
Similar Items
-
DOT1L‐HES6 fusion drives androgen independent growth in prostate cancer
by: Matti Annala, et al.
Published: (2014-07-01) -
Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
by: Xu, X, et al.
Published: (2010) -
Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections
by: Pekka Ruusuvuori, et al.
Published: (2016-01-01) -
β-Microseminoprotein binds CRISP-3 in human seminal plasma
by: Udby, L, et al.
Published: (2005) -
beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
by: Udby, L, et al.
Published: (2005)